Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / S&P PHARMAC
-
Number of holders
-
79
-
Total 13F shares, excl. options
-
2,166,494
-
Shares change
-
-459,412
-
Total reported value, excl. options
-
$112,165,001
-
Value change
-
-$23,374,349
-
Number of buys
-
25
-
Number of sells
-
-37
-
Price
-
$51.76
Significant Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q2 2021
93 filings reported holding XPH - SPDR SERIES TRUST - S&P PHARMAC as of Q2 2021.
SPDR SERIES TRUST - S&P PHARMAC (XPH) has 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,166,494 shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (445,633 shares), MORGAN STANLEY (413,654 shares), BANK OF AMERICA CORP /DE/ (274,448 shares), BNP PARIBAS ARBITRAGE, SA (103,423 shares), LPL Financial LLC (85,025 shares), Wharton Business Group, LLC (76,095 shares), Hochman Cole Investment Advisors, Inc. (54,340 shares), WELLS FARGO & COMPANY/MN (45,964 shares), FIRST CITIZENS BANK & TRUST CO (45,941 shares), and CX Institutional (43,584 shares).
This table shows the top 79 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.